- Zellic is featured in Injective’s latest Validator Spotlight for its advanced security audits and contributions to network governance.
- Zellic offers 0% commission for new delegators during the ongoing validator rebate campaign ending in late July.
Who is Injective highlighting in its latest “Validator Spotlight” edition? Not an old name, but Zellic—a cybersecurity company that has long been better known as an audit partner for giants. From Fortune 500 companies to top-tier DeFi protocols, many have relied on their expertise. But now, Zellic is also the backbone of Injective’s security as an active validator.
Injective Validator Spotlight 🔦
Today, we shine the spotlight on @zellic_io.
Zellic is a major contributor to Injective’s network security by operating a validator among other governance, education, and ecosystem development work.
Zellic is a security powerhouse doing… pic.twitter.com/OYM8ejgtUv
— Injective 🥷 (@injective) June 13, 2025
Zellic Brings Precision and Proactive Defense to Injective
Zellic itself is no ordinary player. They claim that in more than 59% of the audits they conduct, they find crucial issues that almost escape the radar of many other auditors. What does that mean? They not only know the loopholes, but also understand how to prevent chaos before it starts.
At Injective, this role is even more important. With a commitment to maintaining high uptime and a 5% validator commission, they also strengthen the governance and education side of the community. Not enough? They are even participating in Injective’s validator rebate campaign until the end of July. New delegators can get 0% commission if they stake to the Zellic validator during that period.
Interestingly, Zellic is not the only big name to join the Injective network this year. On June 6, BitGo officially joined via Twinstake as a new validator. BitGo, which has handled over $2 trillion worth of digital transactions, brings heavy-duty infrastructure that is suitable for institutional needs.
BitGo’s joining is not only about reputation, but also about the capacity to maintain the security and scalability of the Injective protocol amidst growing interest.
Furthermore, earlier in April, it was Republic’s turn—a venture firm and multi-stage fund manager—to take part as a validator. This collaboration is indeed not just about block validation.
Republic has a mission: to accelerate the tokenization of real-world assets and bridge the needs of institutional DeFi with the world of traditional finance. If we were to put it into perspective, Injective is building the foundation of a “toll bridge” to facilitate access from large institutions to the Web3 kitchen.
Besides that, as of press time, INJ is swapped hands at about $11.76, up 3.40% over the last 24 hours, with daily trading volume at about $88.7 million.
Canary Capital Eyes New ETF Model Backed by Staking Yields
On the other hand, CNF previously also brought up interesting news about Canary Capital’s move to form a Delaware trust. The goal is bold: to lay the groundwork for a potential Injective staking ETF. This model would combine spot exposure with staking returns, something that has not been seriously explored in the crypto space.
Judging by this move, Injective appears to be building a validator ecosystem that can not only block, but also drive innovation and broader trust.
